Daniel Huang

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia

Srđan Verstovšek, Stéphane Courby, Martin Grießhammer et al. · Leukemia Research · 2017 · 41 citations · Full text

Medicine, Hematology, Pharmacology +8

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer

Sukhmani K. Padda, Karen L. Reckamp, Marianna Koczywas et al. · Cancer Chemotherapy and Pharmacology · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacology +14

Longitudinal Outcomes of Medical Student Research Mentorship: a 15-Year Analysis of the Radiation Oncology Mentorship Initiative

Daniel Huang, Muhammad M. Qureshi, Suzanne Sarfaty et al. · Journal of Cancer Education · 2021 · 11 citations

Medicine, Medical Education, Radiation Oncology +13